Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Grape-seed extract kills laboratory leukemia cells, proving value of natural compounds

Grape-seed extract kills laboratory leukemia cells, proving value of natural compounds

January 05, 2009

PHILADELPHIA - An extract from grape seeds forces laboratory leukemia cells to commit cell suicide, according to researchers from the University of Kentucky. They found that within 24 hours, 76 percent of leukemia cells had died after being exposed to the extract.

The investigators, who report their findings in the January 1, 2009, issue of Clinical Cancer Research, a journal of the American Association for Cancer Research, also teased apart the cell signaling pathway associated with use of grape seed extract that led to cell death, or apoptosis. They found that the extract activates JNK, a protein that regulates the apoptotic pathway.




While grape seed extract has shown activity in a number of laboratory cancer cell lines, including skin, breast, colon, lung, stomach and prostate cancers, no one had tested the extract in hematological cancers nor had the precise mechanism for activity been revealed.

"These results could have implications for the incorporation of agents such as grape seed extract into prevention or treatment of hematological malignancies and possibly other cancers," said the study's lead author, Xianglin Shi, Ph.D., professor in the Graduate Center for Toxicology at the University of Kentucky.

"What everyone seeks is an agent that has an effect on cancer cells but leaves normal cells alone, and this shows that grape seed extract fits into this category," he said.

Shi adds, however, that the research is not far enough along to suggest that people should eat grapes, grape seeds, or grape skin in excess to stave off cancer. "This is very promising research, but it is too early to say this is chemo-protective."

Hematological cancers - leukemia, lymphoma and myeloma - accounted for an estimated 118,310 new cancer cases and almost 54,000 deaths in 2006, ranking these cancers as the fourth leading cause of cancer incidence and death in the U.S.

Given that epidemiological evidence shows that eating vegetables and fruits helps prevent cancer development, Shi and his colleagues have been studying chemicals known as proanthocyanidins in fruits that contribute to this effect. Shi has found that apple peel extract contains these flavonoids, which have antioxidant activity, and which cause apoptosis in several cancer cell lines but not in normal cells. Based on those studies, and findings from other researchers that grape seed extract reduces breast tumors in rats and skin tumors in mice, they looked at the effect of the compound in leukemia cells.

Using a commercially available grape seed extract, Shi exposed leukemia cells to the extract in different doses and found the marked effect in causing apoptosis in these cells at one of the higher doses.

They also discovered that the extract does not affect normal cells, although they don't know why.

The researchers then used pharmacologic and genetic approaches to determine how the extract induced apoptosis. They found that the extract strongly activated the JNK pathway, which then led to up-regulation of Cip/p21, which controls the cell cycle.

They checked this finding by using an agent that inhibited JNK, and found that the extract was ineffective. Using a genetic approach - silencing the JNK gene - also disarmed grape seed extract's lethal attack in leukemia cells.

"This is a natural compound that appears to have relatively important properties," Shi said.

American Association for Cancer Research



Related Leukemia Cells Current Events and Leukemia Cells News Articles Leukemia Cells Current Events and Leukemia Cells News RSS Leukemia Cells Current Events and Leukemia Cells News RSS
First use of antibody and stem cell transplantation to successfully treat advanced leukemia
For the first time, researchers at Fred Hutchinson Cancer Research Center have reported the use of a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell transplant, to successfully treat a group of leukemia and pre-leukemia patients for whom there previously had been no other curative treatment options.

Chemosensitivity of cancer cells depends on their protein dependency
Two different anti-apoptotic proteins support cancer cell survival via an identical mechanism, yet differ in their sensitivity to chemotherapeutic drugs, report Brunelle et al. The study will be published online October 26, 2009 and in the November 2, 2009 print issue of the Journal of Cell Biology (JCB).

New research strategy for understanding drug resistance in leukemia
UCSF researchers have developed a new approach to identify specific genes that influence how cancer cells respond to drugs and how they become resistant. This strategy, which involves producing diverse genetic mutations that result in leukemia and associating specific mutations with treatment outcomes, will enable researchers to better understand how drug resistance occurs in leukemia and other cancers, and has important long-term implications for the development of more effective therapies.

Inherited risk factors increase odds of developing childhood acute lymphoblastic leukemia
Scientists at St. Jude Children's Research Hospital have identified inherited variations in two genes that account for 37 percent of childhood acute lymphoblastic leukemia (ALL), including a gene that may help predict drug response.

Comprehensive look at rare leukemia finds relatively few genetic changes launch disease
The most comprehensive analysis yet of the genome of childhood acute myeloid leukemia (AML) found only a few mistakes in the genetic blueprint, suggesting the cancer arises from just a handful of missteps.

Green tea extract shows promise in leukemia trials
Mayo Clinic researchers are reporting positive results in early leukemia clinical trials using the chemical epigallocatechin gallate (EGCG), an active ingredient in green tea.

Researchers find drug that inhibits acute leukemia cell growth
Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have discovered how to turn off a certain receptor that promotes the growth of leukemia cells.

How cells change gears: New insights published in Nature Genetics
Bioinformatics researchers from UC San Diego just moved closer to unlocking the mystery of how human cells switch from "proliferation mode" to "specialization mode." This computational biology work from the Jacobs School of Engineering's bioengineering department could lead to new ideas for curbing unwanted cell proliferation--including some cancers.

Scripps research team invents first technique for producing promising anti-leukemia agent
Kapakahines, marine-derived natural products isolated from a South Pacific sponge in trace quantities, have shown anti-leukemia potential, but studies have been all but stalled by kapakahines' lack of availability.

Therapeutic effect of imatinib improved with addition of chloroquine
The therapeutic effects of the blockbuster leukemia drug imatinib may be enhanced when given along with a drug that inhibits a cell process called autophagy, researchers from the Kimmel Cancer Center at Jefferson reported in the Journal of Clinical Investigation.
More Leukemia Cells Current Events and Leukemia Cells News Articles
Hairy Cell Leukemia Medical Guide

Hairy Cell Leukemia Medical Guide
by Qontro Medical Guides (Author)

The Hairy Cell Leukemia Medical Guide is a publication which has been designed to better help readers understand Hairy Cell Leukemia. This Qontro Medical Guide has been designed with the reader in mind, and is a useful information source for readers at all levels looking to learn more about Hairy Cell Leukemia. The Hairy Cell Leukemia Medical Guide is highly recommended for those interested in understanding and learning more about Hairy Cell Leukemia.

Beating Hairy Cell Leukemia Together T-shirt Large White

Beating Hairy Cell Leukemia Together T-shirt Large White
by Shop Zeus



Cure Hairy Cell Leukemia Mug

Cure Hairy Cell Leukemia Mug
by Design a Product LLC

Text on mug: Cure Hairy Cell Leukemia
* Custom coffee mugs are dishwasher-safe and microwave-safe. Colors are permanently baked into the mug''s surface.
* If you have new ideas or need help selecting text for your custom coffee mugs please contact us.
* Size: 11 oz. capacity ceramic coffee mug.

  Hematopoiesis
by Alexey Bersenev

Analytical reviews and discussions about stem cell research, cell therapy, regenerative medicine, immunology, leukemia researchKindle blogs are fully downloaded onto your Kindle so you can read them even when you're not wirelessly connected. And unlike RSS readers which often only provide headlines, blogs on Kindle give you full text content and images, and are updated wirelessly throughout the day.

Can We Cure the Common Leukemias?

Can We Cure the Common Leukemias?



Enzymatic Therapy - Cell Fotré w/ IP-6 & Inositol - Deep Immune Support - 240 Tablets

Enzymatic Therapy - Cell Fotré w/ IP-6 & Inositol - Deep Immune Support - 240 Tablets
by Enzymatic Therapy

This special blend of IP-6 and inositol delivers scientifically-studied, exceptional support for the most critical cells in your immune system. This patented combination boosts your defenses by increasing the levels of inositol phosphates in the cellsnatural substances found in your body to help enhance the immune system.

21st Century Ultimate Medical Guide to Hairy Cell Leukemia - Authoritative, Practical Clinical Information for Physicians and Patients, Treatment Options (Two CD-ROM Set)

21st Century Ultimate Medical Guide to Hairy Cell Leukemia - Authoritative, Practical Clinical Information for Physicians and Patients, Treatment Options (Two CD-ROM Set)
by PM Medical Health News (Author)

This up-to-date and comprehensive set of two CD-ROM discs provides a superb collection of official Federal government documents on Hairy Cell Leukemia: signs and symptoms, diagnosis, lab tests, treatment and management options, and ongoing clinical research. Every aspect of the disease is thoroughly covered. Hairy cell leukemia is a rare type of leukemia in which abnormal B-lymphocytes (a type of white blood cell) are present in the bone marrow, spleen, and peripheral blood. When viewed under a microscope, these cells appear to be covered with tiny hair-like projections. For patients, practical information is provided in clearly written patient education documents. For medical professionals, doctor references and texts have detailed technical information and clinical background...

Hairy Cell Leukemia, An Issue of Hematology/Oncology Clinics (The Clinics: Internal Medicine)

Hairy Cell Leukemia, An Issue of Hematology/Oncology Clinics (The Clinics: Internal Medicine)
by A. Saven (Author)

Hairy cell leukemia (HCL) has assumed a level of great medical importance, despite its relative rarity as a chronic lymphoid leukemia. This is because it is a unique, and peculiar, clinicopathologic entity which demonstrates unparalleled sensitivity to systemic therapy. Accordingly, it has served as a model for rational drug development. Although splenectomy regularly normalizes the disease-associated cytopenias, it is now principally of historic interest because there are three agents approved to treat HCL, namely, interferon, pentostatin and cladribine. We found that single infusions of cladribine, administered continuously over seven days, induce response rates greater than 95%, 85% of which are complete and durable. More recently, the monoclonal antibody, rituximab, and the...

Cure Hairy Cell Leukemia Long Sleeve T-shirt Large White

Cure Hairy Cell Leukemia Long Sleeve T-shirt Large White
by Shop Zeus



The Official Patient's Sourcebook on Hairy Cell Leukemia

The Official Patient's Sourcebook on Hairy Cell Leukemia
by James N. Parker (Author), Philip M. Parker (Author)

This book has been created for patients who have decided to make education and research an integral part of the treatment process. Although it also gives information useful to doctors, caregivers and other health professionals, it tells patients where and how to look for information covering virtually all topics related to hairy cell leukemia (also leukemic reticuloendotheliosis), from the essentials to the most advanced areas of research. The title of this book includes the word official. This reflects the fact that the sourcebook draws from public, academic, government, and peer-reviewed research. Selected readings from various agencies are reproduced to give you some of the latest official information available to date on hairy cell leukemia. Given patients' increasing sophistication...

© 2009 BrightSurf.com